pharmacodynamic effects

Related by string. * pharmacodynamics . Pharmacodynamic . Pharmacodynamics : safety tolerability pharmacodynamics . pharmacodynamic parameters . pharmacokinetic pharmacodynamic PK PD . pharmacodynamic profile . pharmacokinetic pharmacodynamic / effected . effecting . Effects . EFFECTS . EFFECT : REMAINS IN EFFECT UNTIL . Mass Effect . visual effects . chilling effect . Side Effects * *

Related by context. Frequent words. (Click for all words.) 70 pharmacodynamic 68 Pharmacokinetic 68 safety tolerability pharmacokinetics 68 pertuzumab 68 Azedra 67 pharmacokinetic profile 67 nab paclitaxel 67 PXD# 66 pharmacokinetics 66 pharmacokinetic studies 66 Phase 1b trial 66 pharmacodynamics 66 HGS ETR1 66 CR# vcMMAE 65 pharmacokinetic 65 IMC A# 65 tanespimycin 65 imetelstat 64 vitro experiments 64 CA4P 64 tolerated dose MTD 64 antitumor activity 64 radiolabeled 64 ISIS # 64 Phase Ia 64 BAY #-# 64 CoFactor 64 PS# [001] 64 Phase 2b study 64 DAVANAT 64 Phase 2a trial 64 LY# [002] 64 NGX# 64 placebo controlled clinical 64 Phase 1a 63 Ostarine 63 NU# [001] 63 ZD# [001] 63 Phase 1b 63 orally bioavailable 63 TRIOLEX 63 pharmacokinetic profiles 63 Sym# 63 eniluracil 63 SCH # 63 Phase IIa trial 63 OXi# 63 Secondary endpoints 63 talabostat 63 peripheral blood mononuclear 63 axitinib 63 Zemiva 63 administered subcutaneously 62 tolerability 62 active comparator 62 cardiac toxicity 62 dose escalation trial 62 teduglutide 62 dose limiting toxicities 62 Carfilzomib 62 Phase Ib 62 deforolimus 62 phase IIa 62 Lp PLA2 62 C1 INH 62 rNAPc2 62 efficacy 62 PRX# 61 CTCE 61 HuMax CD# 61 safety tolerability 61 dose escalation 61 subgroup analyzes 61 thymalfasin 61 multiple ascending dose 61 mycophenolate mofetil 61 LY# [003] 61 PROMACTA 61 achieved statistical significance 61 angiogenesis inhibitor 61 serum concentrations 61 GRN#L 61 dose escalation study 61 glatiramer acetate 61 SRT# [003] 61 Navelbine 61 eltrombopag 61 intravenously administered 61 glucose lowering 61 PRX # 61 Secondary endpoints include 61 immunohistochemical 61 #mg dose [001] 61 placebo controlled randomized 61 decitabine 61 #ME# 60 6R BH4 60 RG# [001] 60 double blinded placebo 60 registrational 60 MIRCERA

Back to home page